Works matching AU Christophe, Borg

Results: 103

Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study.

Published in:

Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf080

By:

Blanc, Jean-Frédéric;
Bouattour, Mohamed;
Gauthier, Ludovic;
Deshayes, Emmanuel;
Guillemard, Sophie;
Touchefeu, Yann;
Portales, Fabienne;
Borg, Christophe;
Harguem, Lobna;
Guimbaud, Rosine;
Mineur, Laurent;
Ychou, Marc;
Mazard, Thibault;
Assenat, Eric

Publication type:

Article

FOLFIRINOX De‐Escalation in Advanced Pancreatic Cancer: A Multicenter Real‐Life Study.

Published in:

Oncologist, 2020, v. 25, n. 11, p. e1701, doi. 10.1634/theoncologist.2020-0577

By:

Chevalier, Hortense;
Vienot, Angélique;
Lièvre, Astrid;
Edeline, Julien;
El Hajbi, Farid;
Peugniez, Charlotte;
Vernerey, Dewi;
Meurisse, Aurélia;
Hammel, Pascal;
Neuzillet, Cindy;
Borg, Christophe;
Turpin, Anthony

Publication type:

Article

Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial.

Published in:

Medical Oncology, 2016, v. 33, n. 8, p. 1, doi. 10.1007/s12032-016-0806-0

By:

Calcagno, Fabien;
Mouillet, Guillaume;
Adotevi, Olivier;
Maurina, Tristan;
Nguyen, Thierry;
Montcuquet, Philippe;
Curtit, E.;
Kleinclauss, F.;
Pivot, Xavier;
Borg, Christophe;
Thiery-Vuillemin, Antoine

Publication type:

Article

The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas.

Published in:

Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0148-y

By:

Kim, Stefano;
Fiteni, Frederic;
Paget-Bailly, Sophie;
Ghiringhelli, François;
Lakkis, Zaher;
Jary, Marine;
Fein, Francine;
Bonnetain, Franck;
Mariette, Christophe;
Borg, Christophe

Publication type:

Article

Constitutional and somatic deletions of the Williams-Beuren syndrome critical region in Non- Hodgkin's Lymphoma.

Published in:

Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/s13045-014-0082-4

By:

Guenat, David;
Quentin, Samuel;
Rizzari, Carmelo;
Lundin, Catarina;
Coliva, Tiziana;
Edery, Patrick;
Fryssira, Helen;
Bermont, Laurent;
Ferrand, Christophe;
Soulier, Jean;
Christophe, Borg;
Rohrlich, Pierre-Simon

Publication type:

Article

SALL4‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features.

Published in:

Molecular Oncology, 2023, v. 17, n. 7, p. 1356, doi. 10.1002/1878-0261.13370

By:

Vienot, Angélique;
Monnien, Franck;
Truntzer, Caroline;
Mougey, Virginie;
Bouard, Adeline;
Pallandre, Jean‐René;
Molimard, Chloé;
Loyon, Romain;
Asgarov, Kamal;
Averous, Gerlinde;
Ghiringhelli, François;
Bibeau, Frédéric;
Peixoto, Paul;
Borg, Christophe

Publication type:

Article

Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2260, doi. 10.1002/1878-0261.13173

By:

Jary, Marine;
Wen-Wei Liu;
Dongyao Yan;
Bai, Isaac;
Muranyi, Andrea;
Colle, Elise;
Brocheriou, Isabelle;
Turpin, Anthony;
Radosevic-Robin, Nina;
Bourgoin, Pierre;
Penault-Llorca, Frédérique;
Cohen, Romain;
Vernerey, Dewi;
André, Thierry;
Borg, Christophe;
Shanmugam, Kandavel;
Svrcek, Magali

Publication type:

Article

A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen.

Published in:

2017

By:

Lereclus, Emilie;
Tout, Mira;
Girault, Alban;
Baroukh, Nadine;
Caulet, Morgane;
Borg, Christophe;
Bouché, Olivier;
Ternant, David;
Paintaud, Gilles;
Lecomte, Thierry;
Raoul, William

Publication type:

journal article

Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery.

Published in:

Biomedicines, 2024, v. 12, n. 12, p. 2754, doi. 10.3390/biomedicines12122754

By:

Truntzer, Caroline;
Ouahbi, Dina;
Huppé, Titouan;
Rageot, David;
Ilie, Alis;
Molimard, Chloe;
Beltjens, Françoise;
Bergeron, Anthony;
Vienot, Angelique;
Borg, Christophe;
Monnien, Franck;
Bibeau, Frédéric;
Derangère, Valentin;
Ghiringhelli, François

Publication type:

Article

The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

Published in:

Biomedicines, 2021, v. 9, n. 6, p. 665, doi. 10.3390/biomedicines9060665

By:

Aftimos, Philippe;
Rolfo, Christian;
Rottey, Sylvie;
Barthélémy, Philippe;
Borg, Christophe;
Park, Keunchil;
Oh, Do-Youn;
Kim, Sang-We;
De Jonge, Natalie;
Hanssens, Valérie;
Zwanenpoel, Karen;
Molthoff, Carla;
Vugts, Daniëlle;
Dreier, Torsten;
Verheesen, Peter;
van Dongen, Guus A.M.S.;
Jacobs, Julie;
Van Rompaey, Luc;
Hultberg, Anna;
Michieli, Paolo

Publication type:

Article

Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.

Published in:

Cancer Medicine, 2018, v. 7, n. 11, p. 5382, doi. 10.1002/cam4.1703

By:

Fogelman, David;
Cubillo, Antonio;
García‐Alfonso, Pilar;
Mirón, María Luisa Limón;
Nemunaitis, John;
Flora, Daniel;
Borg, Christophe;
Mineur, Laurent;
Vieitez, Jose M.;
Cohn, Allen;
Saylors, Gene;
Assad, Albert;
Switzky, Julie;
Zhou, Li;
Bendell, Johanna

Publication type:

Article

Docetaxel, Cisplatin, and 5-Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma.

Published in:

Cancer Medicine, 2016, v. 5, n. 11, p. 3085, doi. 10.1002/cam4.885

By:

Fiteni, Frédéric;
Paget ‐ Bailly, Sophie;
Messager, Mathieu;
N'Guyen, Thierry;
Lakkis, Zaher;
Mathieu, Pierre;
Lamfichekh, Najib;
Picard, Alain;
Benzidane, Bilell;
Cléau, Denis;
Bonnetain, Franck;
Borg, Christophe;
Mariette, Christophe;
Kim, Stefano

Publication type:

Article

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.

Published in:

Cancer Medicine, 2014, v. 3, n. 6, p. 1502, doi. 10.1002/cam4.299

By:

Fiteni, Frédéric;
Nguyen, Thierry;
Vernerey, Dewi;
Paillard, Marie‐Justine;
Kim, Stefano;
Demarchi, Martin;
Fein, Francine;
Borg, Christophe;
Bonnetain, Franck;
Pivot, Xavier

Publication type:

Article

ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes.

Published in:

Cells (2073-4409), 2018, v. 7, n. 12, p. 248, doi. 10.3390/cells7120248

By:

Claude-Taupin, Aurore;
Fonderflick, Leïla;
Gauthier, Thierry;
Mansi, Laura;
Pallandre, Jean-René;
Borg, Christophe;
Perez, Valérie;
Monnien, Franck;
Algros, Marie-Paule;
Vigneron, Marc;
Adami, Pascale;
Delage-Mourroux, Régis;
Peixoto, Paul;
Herfs, Michael;
Boyer-Guittaut, Michaël;
Hervouet, Eric

Publication type:

Article

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.683289

By:

d'Engremont, Christelle;
Grillot, Julienne;
Raillat, Julie;
Vernerey, Dewi;
Vuitton, Lucine;
Koch, Stéphane;
Turco, Célia;
Heyd, Bruno;
Mouillet, Guillaume;
Jacquinot, Quentin;
Borg, Christophe;
Vienot, Angélique

Publication type:

Article

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22764-2

By:

Ercolano, Giuseppe;
Gomez-Cadena, Alejandra;
Dumauthioz, Nina;
Vanoni, Giulia;
Kreutzfeldt, Mario;
Wyss, Tania;
Michalik, Liliane;
Loyon, Romain;
Ianaro, Angela;
Ho, Ping-Chih;
Borg, Christophe;
Kopf, Manfred;
Merkler, Doron;
Krebs, Philippe;
Romero, Pedro;
Trabanelli, Sara;
Jandus, Camilla

Publication type:

Article

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.

Published in:

2010

By:

Chalmin, Fanny;
Ladoire, Sylvain;
Mignot, Grégoire;
Vincent, Julie;
Bruchard, Mélanie;
Remy-Martin, Jean-Paul;
Boireau, Wilfrid;
Rouleau, Alain;
Simon, Benoit;
Lanneau, David;
De Thonel, Aurélie;
Multhoff, Gabriele;
Hamman, Arlette;
Martin, François;
Chauffert, Bruno;
Solary, Eric;
Zitvogel, Laurence;
Garrido, Carmen;
Ryffel, Bernhard;
Borg, Christophe

Publication type:

journal article

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell --dependent antitumor effects.

Published in:

Journal of Clinical Investigation, 2004, v. 114, n. 3, p. 379, doi. 10.1172/JCI200421102

By:

Borg, Christophe;
Terme, Magali;
Taieb, Julien;
Ménard, Cedric;
Flament, Caroline;
Robert, Caroline;
Maruyama, Koji;
Wakasugi, Hiro;
Angevin, Eric;
Thielemans, Kris;
Cesne, Axel Le;
Chung-Scott, Véronique;
Lazar, Vladimir;
Tchou, Isabelle;
Crépineau, Florent;
Lemoine, François;
Bernard, Jacky;
Fletcher, Jonhantan A.;
Turhan, Ali;
Biay, Jean-Yves

Publication type:

Article

Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 141, doi. 10.1007/s00280-014-2482-0

By:

Jary, Marine;
Ghiringhelli, Francois;
Jacquin, Marion;
Fein, Francine;
Nguyen, Thierry;
Cleau, Denis;
Nerich, Virginie;
El Gani, Maryame;
Mathieu, Pierre;
Valmary-Degano, Séverine;
Arnould, Laurent;
Lassabe, Catherine;
Lamfichekh, Najib;
Fratté, Serge;
Paget-Bailly, Sophie;
Bonnetain, Franck;
Borg, Christophe;
Kim, Stefano

Publication type:

Article

Loss of central and peripheral CD8<sup>+</sup> T-cell tolerance to HFE in mouse models of human familial hemochromatosis.

Published in:

European Journal of Immunology, 2012, v. 42, n. 4, p. 851, doi. 10.1002/eji.201141664

By:

Boucherma, Rachid;
Kridane-Miledi, Hédia;
Langa Vives, Francina;
Vauchy, Charline;
Borg, Christophe;
Kleinclauss, François;
Fiette, Laurence;
Tiberghien, Pierre;
Lemonnier, François A.;
Rohrlich, Pierre S.;
Huetz, François

Publication type:

Article

Anti-Telomerase CD4+ Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6838, doi. 10.3390/ijms21186838

By:

Spehner, Laurie;
Kim, Stefano;
Vienot, Angélique;
François, Eric;
Buecher, Bruno;
Adotevi, Olivier;
Vernerey, Dewi;
Abdeljaoued, Syrine;
Meurisse, Aurélia;
Borg, Christophe

Publication type:

Article

The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1673, doi. 10.3390/ijms21051673

By:

Renaude, Elodie;
Kroemer, Marie;
Loyon, Romain;
Binda, Delphine;
Borg, Christophe;
Guittaut, Michaël;
Hervouet, Eric;
Peixoto, Paul

Publication type:

Article

Controlled Contact between Beads and Cells for the Characterization of Receptor–Ligand Bonds †.

Published in:

2024

By:

Lipp, Clémentine;
Koebel, Laure;
Loyon, Romain;
Bolopion, Aude;
Spehner, Laurie;
Gauthier, Michaël;
Borg, Christophe;
Bertsch, Arnaud;
Renaud, Philippe

Publication type:

Abstract

Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.

Published in:

Human Vaccines & Immunotherapeutics, 2013, v. 9, n. 5, p. 1073, doi. 10.4161/hv.23587

By:

Adotévi, Olivier;
Dosset, Magalie;
Galaine, Jeanne;
Beziaud, Laurent;
Godet, Yann;
Borg, Christophe

Publication type:

Article

Confounding mitigation for the exposure‐response relationship of bevacizumab in colorectal cancer patients.

Published in:

British Journal of Clinical Pharmacology, 2024, v. 90, n. 4, p. 976, doi. 10.1111/bcp.15983

By:

Lobet, Sarah;
Caulet, Morgane;
Paintaud, Gilles;
Azzopardi, Nicolas;
Desvignes, Céline;
Chautard, Romain;
Borg, Christophe;
Capitain, Olivier;
Ferru, Aurélie;
Bouché, Olivier;
Lecomte, Thierry;
Ternant, David

Publication type:

Article

Exposure‐response analysis of Raltitrexed assessing liver toxicity.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1327, doi. 10.1111/bcp.14519

By:

Royer, Bernard;
Schmitt, Antonin;
Nguyen, Thierry;
Paillard, Marie‐Justine;
Jary, Marine;
Demarchi, Martin;
Vernerey, Dewi;
Henriques, Julie;
Jacquin, Marion;
Borg, Christophe;
Kim, Stefano

Publication type:

Article

CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy.

Published in:

OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2023.2294563

By:

Schoumacher, Coralie;
Derangère, Valentin;
Gaudillière-Le Dain, Gwladys;
Huppe, Titouan;
Rageot, David;
Ilie, Alis;
Vienot, Angélique;
Borg, Christophe;
Monnien, Franck;
Bibeau, Frederic;
Truntzer, Caroline;
Ghiringhelli, François

Publication type:

Article

Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy.

Published in:

OncoImmunology, 2022, v. 11, n. 1, p. 1, doi. 10.1080/2162402X.2022.2144669

By:

Vienot, Angélique;
Pallandre, Jean-René;
Renaude, Elodie;
Viot, Julien;
Bouard, Adeline;
Spehner, Laurie;
Kroemer, Marie;
Abdeljaoued, Syrine;
van der Woning, Bas;
de Haard, Hans;
Loyon, Romain;
Hervouet, Eric;
Peixoto, Paul;
Borg, Christophe

Publication type:

Article

Circulating NKp46<sup>+</sup> Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.

Published in:

OncoImmunology, 2019, v. 8, n. 2, p. 1, doi. 10.1080/2162402X.2018.1527498

By:

Picard, Emilie;
Godet, Yann;
Laheurte, Caroline;
Dosset, Magalie;
Galaine, Jeanne;
Beziaud, Laurent;
Loyon, Romain;
Boullerot, Laura;
Lauret Marie Joseph, Elodie;
Spehner, Laurie;
Jacquin, Marion;
Eberst, Guillaume;
Gaugler, Béatrice;
Le pimpec-Barthes, Françoise;
Fabre, Elizabeth;
Westeel, Virginie;
Caignard, Anne;
Borg, Christophe;
Adotévi, Olivier

Publication type:

Article

Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study.

Published in:

OncoImmunology, 2018, v. 7, n. 9, p. 1, doi. 10.1080/2162402X.2018.1474319

By:

Isambert, Nicolas;
Hervieu, Alice;
Hennequin, Audrey;
Zanetta, Sylvie;
Rébé, Cedric;
Chevriaux, Angélique;
Richard, Corentin;
Derangère, Valentin;
Limagne, Emeric;
Ghiringhelli, François;
Borg, Christophe;
Blanc, Julie;
Bertaut, Aurélie

Publication type:

Article

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.

Published in:

OncoImmunology, 2018, v. 7, n. 6, p. 1, doi. 10.1080/2162402X.2018.1433981

By:

Dosset, Magalie;
Vargas, Thaiz Rivera;
Lagrange, Anaïs;
Boidot, Romain;
Végran, Frédérique;
Roussey, Aurélie;
Chalmin, Fanny;
Dondaine, Lucile;
Paul, Catherine;
Marie-Joseph, Elodie Lauret;
Martin, François;
Ryffel, Bernhard;
Borg, Christophe;
Adotévi, Olivier;
Ghiringhelli, François;
Apetoh, Lionel

Publication type:

Article

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.

Published in:

OncoImmunology, 2018, v. 7, n. 4, p. 1, doi. 10.1080/2162402X.2017.1412030

By:

Kroemer, Marie;
Spehner, Laurie;
Mercier-Letondal, Patricia;
Boullerot, Laura;
Kim, Stefano;
Jary, Marine;
Galaine, Jeanne;
Picard, Emilie;
Ferrand, Christophe;
Nguyen, Thierry;
Larosa, Fabrice;
Adotévi, Olivier;
Godet, Yann;
Borg, Christophe

Publication type:

Article

Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer.

Published in:

OncoImmunology, 2017, v. 6, n. 1, p. 1, doi. 10.1080/2162402X.2016.1163456

By:

Fend, Laetitia;
Rusakiewicz, Sylvie;
Adam, Julien;
Bastien, Bérangère;
Caignard, Anne;
Messaoudene, Meriem;
Iribarren, Christina;
Cremer, Isabelle;
Marabelle, Aurélien;
Borg, Christophe;
Semeraro, Michaela;
Barraud, Luc;
Limacher, Jean-Marc;
Eggermont, Alexander;
Kroemer, Guido;
Zitvogel, Laurence

Publication type:

Article

Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4 Th1 responses against telomerase in cancer patients.

Published in:

OncoImmunology, 2016, v. 5, n. 5, p. 1, doi. 10.1080/2162402X.2015.1137416

By:

Laheurte, Caroline;
Galaine, Jeanne;
Beziaud, Laurent;
Dosset, Magalie;
Kerzerho, Jerome;
Jacquemard, Claire;
Gaugler, Béatrice;
Ferrand, Christophe;
Dormoy, Anne;
Aubin, François;
Jacoulet, Pascale;
Westeel, Virginie;
Borg, Christophe;
Tartour, Eric;
Godet, Yann;
Maillère, Bernard;
Adotévi, Olivier

Publication type:

Article

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

Published in:

OncoImmunology, 2012, v. 1, n. 9, p. 1, doi. 10.4161/onci.21513

By:

Godet, Yann;
Dosset, Magalie;
Borg, Christophe;
Adotevi, Olivier

Publication type:

Article

Comparison of a selective STAT3 inhibitor with a dual STAT3/STAT1 inhibitor using a dextran sulfate sodium murine colitis model: new insight into the debate on selectivity.

Published in:

Annals of Gastroenterology, 2024, v. 37, n. 3, p. 333, doi. 10.20524/aog.2024.0880

By:

Moulari, Brice;
Pallandre, Jean-Réné;
Béduneau, Arnaud;
Borg, Christophe;
Pellequer, Yann;
Pudlo, Marc

Publication type:

Article

Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial.

Published in:

Cancer Imaging, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s40644-024-00722-7

By:

Mazard, Thibault;
Mollevi, Caroline;
Loyer, Evelyne M.;
Léger, Julie;
Chautard, Romain;
Bouché, Olivier;
Borg, Christophe;
Armand-Dujardin, Paul;
Bleuzen, Aurore;
Assenat, Eric;
Lecomte, Thierry

Publication type:

Article

Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients.

Published in:

Transplant International, 2012, v. 25, n. 9, p. 948, doi. 10.1111/j.1432-2277.2012.01521.x

By:

Courivaud, Cécile;
Bamoulid, Jamal;
Gaugler, Béatrice;
Roubiou, Caroline;
Arregui, Charlène;
Chalopin, Jean-Marc;
Borg, Christophe;
Tiberghien, Pierre;
Woronoff-Lemsi, Marie-Christine;
Saas, Philippe;
Ducloux, Didier

Publication type:

Article

Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 9, p. 2357, doi. 10.1007/s00432-019-02970-8

By:

Ghiringhelli, Francois;
Vincent, Julie;
Bengrine, Leila;
Borg, Christophe;
Jouve, Jean Louis;
Loffroy, Romaric;
Guiu, Boris;
Blanc, Julie;
Bertaut, Aurélie

Publication type:

Article

Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients.

Published in:

2016

By:

Caulet, Morgane;
Lecomte, Thierry;
Bouché, Olivier;
Rollin, Jérôme;
Gouilleux-Gruart, Valérie;
Azzopardi, Nicolas;
Léger, Julie;
Borg, Christophe;
Douillard, Jean-Yves;
Manfredi, Sylvain;
Smith, Denis;
Capitain, Olivier;
Ferru, Aurélie;
Moussata, Driffa;
Terrebone, Eric;
Paintaud, Gilles;
Ternant, David;
Bouché, Olivier;
Rollin, Jérôme;
Gouilleux-Gruart, Valérie

Publication type:

journal article

EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas.

Published in:

Cancers, 2020, v. 12, n. 12, p. 3649, doi. 10.3390/cancers12123649

By:

Lachat, Camille;
Bruyère, Diane;
Etcheverry, Amandine;
Aubry, Marc;
Mosser, Jean;
Warda, Walid;
Herfs, Michaël;
Hendrick, Elodie;
Ferrand, Christophe;
Borg, Christophe;
Delage-Mourroux, Régis;
Feugeas, Jean-Paul;
Guittaut, Michaël;
Hervouet, Eric;
Peixoto, Paul

Publication type:

Article

Neuropilins: A New Target for Cancer Therapy.

Published in:

Cancers, 2011, v. 3, n. 2, p. 1899, doi. 10.3390/cancers3021899

By:

Grandclement, Camille;
Borg, Christophe

Publication type:

Article

Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice.

Published in:

Clinical Medicine Insights: Oncology, 2016, n. 10, p. 59, doi. 10.4137/CMO.s38335

By:

Calcagno, Fabien;
Lenoble, Sabrina;
Lakkis, Zaher;
Nguyen, Thierry;
Limat, Samuel;
Borg, Christophe;
Jary, Marine;
Kim, Stefano;
Nerich, Virginie

Publication type:

Article

Biomarqueurs actuels et à venir dans les cancers œsogastriques.

Published in:

Hépato-Gastro & Oncologie Digestive, 2023, v. 30, p. 7, doi. 10.1684/hpg.2023.2630

By:

Bibeau, Frédéric;
Monnien, Franck;
Laydi, Maxime;
Mathieu, Pierre;
Viennot, Angélique;
Viot, Julien;
Borg, Christophe;
Overs, Alexis;
Molimard, Chloé

Publication type:

Article

Prise en charge du carcinome épidermoïde avancé du canal anal.

Published in:

Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 9, p. 873, doi. 10.1684/hpg.2020.2025

By:

Stouvenot, Morgane;
Vuitton, Lucine;
Meurisse, Aurélia;
Spehner, Laurie;
Jacquin, Marion;
Fein, Francine;
Klajer, Élodie;
Vienot, Angélique;
Boulbair, Fatiha;
Pernot, Mandy;
Jary, Marine;
Borg, Christophe;
Kim, Stefano

Publication type:

Article

Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.

Published in:

2019

By:

Borg, Christophe;
Mantion, Georges;
Boudghene, Frank;
Mornex, Fran<;oise;
Ghiringhelli, Francois;
Adenis, Antoine;
Azria, David;
Balosso, Jacques;
Abdelghani, Meher Ben;
Bachet, Jean Baptiste;
Vendrely, Veronique;
Francois, Yves;
Conroy, Thierry;
Rio, Emmanuel;
Roullet, Bernard;
Spaeth, Dominique;
Quero, Laurent;
Lakkis, Zaher;
Coudert, Mathieu;
Ionescu-Goga, Miruna

Publication type:

journal article

Complete Response to Aflibercept-FOLFIRI in One Patient With Colorectal Cancer Refractory to Bevacizumab-FOLFOX: A Possible Autocrine Vascular Endothelial Growth Factor Receptor 2-Related Mechanism.

Published in:

2016

By:

Kim, Stefano;
Cayre, Anne;
Jary, Marine;
Jacquin, Marion;
Arbez-Gindre, Francine;
Fein, Francine;
Lakkis, Zaher;
Nguyen, Thierry;
Borg, Christophe

Publication type:

journal article

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.

Published in:

2013

By:

Dobi, Erion;
Monnien, Franck;
Kim, Stefano;
Ivanaj, Arben;
N'guyen, Thiery;
Demarchi, Martin;
Adotevi, Olivier;
Thierry-Vuillemin, Antoine;
Jary, Marie;
Kantelip, Bernadette;
Pivot, Xavier;
Godet, Yann;
Degano, Severine Valmary;
Borg, Christophe

Publication type:

journal article

Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer.

Published in:

Clinical Colorectal Cancer, 2013, v. 12, n. 1, p. 28, doi. 10.1016/j.clcc.2012.09.002

By:

Dobi, Erion;
Monnien, Franck;
Kim, Stefano;
Ivanaj, Arben;
N’Guyen, Thiery;
Demarchi, Martin;
Adotevi, Olivier;
Thierry-Vuillemin, Antoine;
Jary, Marie;
Kantelip, Bernadette;
Pivot, Xavier;
Godet, Yann;
Valmary Degano, Severine;
Borg, Christophe

Publication type:

Article

Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.

Published in:

2012

By:

Bennouna, J;
Borg, C;
Delord, JP;
Husseini, F;
Trillet-Lenoir, V;
Faroux, R;
François, E;
Ychou, M;
Goldwasser, F;
Bouché, O;
Senellart, H;
Kraemer, S;
Douillard, JY;
Bennouna, Jaafar;
Borg, Christophe;
Delord, Jean-Pierre;
Husseini, Faress;
Trillet-Lenoir, Véronique;
Faroux, Roger;
François, Eric

Publication type:

journal article